Polymorphisms within the vitamin B12 dependent methylmalonyl-coA mutase are not risk factors for neural tube defects

Molecular Genetics and Metabolism

Volumn 80, Issue 4, 2003, Pages 463-468

  Parle McDermott, Anne ^a   McManus, Edward J ^a   Mills, James L ^b   O'Leary, Valerie B ^a   Pangilinan, Faith ^c   Cox, Christopher ^b   Weiler, Andrea ^c   Molloy, Anne M ^a   Conley, Mary ^b   Watson, Deborah ^d   Scott, John M ^a   Brody, Lawrence C ^c   Kirke, Peadar N ^d  

^a TRINITY COLLEGE DUBLIN   (Ireland)

^b EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^c NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^d HEALTH RESEARCH BOARD   (Ireland)

Author keywords

B12; Folate; Homocysteine; Methylmalonyl CoA; MMA; MTHFR; MUT; Neural tube defects; Spina Bifida

Indexed keywords

CYANOCOBALAMIN; ENZYME VARIANT; METHYLMALONYL COENZYME A MUTASE;

ARTICLE; CHILD; CONTROLLED STUDY; ENCEPHALOCELE; FEMALE; GENE FREQUENCY; HUMAN; MAJOR CLINICAL STUDY; MALE; NEURAL TUBE DEFECT; PRIORITY JOURNAL; RACE DIFFERENCE; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; SPINA BIFIDA; CASE CONTROL STUDY; GENE LINKAGE DISEQUILIBRIUM; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; METABOLISM; PEDIGREE; PRESCHOOL CHILD; RACE; STATISTICAL MODEL;

CASE-CONTROL STUDIES; CHILD, PRESCHOOL; CONTINENTAL POPULATION GROUPS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LINEAR MODELS; LINKAGE DISEQUILIBRIUM; MALE; METHYLMALONYL-COA MUTASE; NEURAL TUBE DEFECTS; PEDIGREE; POLYMORPHISM, GENETIC; RISK FACTORS; VITAMIN B 12;

EID: 0345356231     PISSN: 10967192     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ymgme.2003.09.009     Document Type: Article

References (52)

1. Botto L.D., Yang Q. 5,10-Methylenetetrahydrofolate reductase gene variants and congenital anomalies: a HuGE review. Am. J. Epidemiol. 151:2000;862-877.
2. van der Put N.M.J., Steegers-Theunissen R.P.M., Frosst P., Trijbels J.M., Eskes T.K.A.B., van den Heuvel L.P., Mariman E.C.M., den Heyer M., Rozen R., Blom H.J. Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida. Lancet. 346:1995;1070-1071.
3. Shields D.C., Kirke P.N., Mills J.L., Ramsbottom D., Molloy A.M., Burke H., Weir D.G., Scott J.M., Whitehead A.S. The Thermolabile variant of methylenetetrahydrofolate reductase and neural tube defects: an evaluation of genetic risk and the relative importance of the genotypes of the embryo and the mother. Am. J. Hum. Genet. 64:1999;1045-1055.
4. van der Put N.M.J., Gabreels F., Stevens E.M.B., Smeitink J.A.M., Trijbels F.J.M., Eskes T.K.A.B., van den Heuvel L.P., Blom H.J. A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects? Am. J. Hum. Genet. 62:1998;1044-1051.
5. Parle-McDermott A., Mills J.L., Kirke P.N., O'Leary V.B., Swanson D.A., Pangilinan F., Conley M., Molloy A.M., Cox C., Scott J.M., Brody L.C. Analysis of the MTHFR 1298A. → C and 677C → T polymorphisms as risk factors for neural tube defects J. Hum. Genet. 48:2003;190-193.
6. Hol F.A., van der Put N.M.J., Geurds M.P.A., Heil S.G., Trijbels F.J.M., Hamel B.C.J., Mariman E.C.M., Blom H.J. Molecular genetic analysis of the gene encoding the trifunctional enzyme MTHFD (methylenetetrahydrofolate- dehydrogenase, methenyltetrahydrofolate-cyclohydrolase, formyltetrahydrofin in patients with neural tube defects. Clin. Genet. 53:1998;119-125.
7. Brody L.C., Conley M., Cox C., Kirke P.N., McKeever M.P., Mills J.L., Molloy A.M., O'Leary V.B., Parle-McDermott A., Scott J.M., Swanson D.A. A polymorphism R653Q, in the trifunctional enzyme methylenetetrahydrofolate dehydrogenase/methenyltetrahydrofolate cyclohydrolase/formyltetrahydrofolate synthetase is a maternal genetic risk factor for neural tube defects: report of the Birth Defects Research Group. Am. J. Hum. Genet. 71:2002;1207-2115.
8. MRC Vitamin Study Research Group, Prevention of neural tube defects: results of the Medical Research Council vitamin study, Lancet 338 (1991) 131-137.
9. Czeizel A.E., Dudas I. Prevention of the first occurrence of neural tube defects by periconceptional vitamin supplementation. N. Engl. J. Med. 327:1992;1832-1835.
10. Molloy A.M., Mills J.L., Kirke P.N., Ramsbottom D., McPartlin J.M., Burke H., Conley M., Whitehead A.S., Weir D.G., Scott J.M. Low blood folates in NTD pregnancies are only partly explained by thermolabile 5,10- methylenetetrahydrofolate reductase: low folate status alone may be the critical factor. Am. J. Med. Genet. 78:1998;155-159.
11. 12 and transcobalamins in neural tube defects. Clin. Genet. 33:1988;441-448.
12. Weekes E.W., Tamura T., Davis R.O., Birch R., Vaughn W.H., Franklin J.C., Barganier C., Cosper P., Finley S.C., Finley W.H. Nutrient levels in amniotic fluid from women with normal and neural tube defect pregnancies. Biol. Neonate. 61:1992;226-231.
13. 12 concentrations in maternal and fetal blood, and amniotic fluid in second trimester pregnancies complicated by neural tube defects. Br. J. Obstet Gynaecol. 99:1992;23-25.
14. 12 are independent risk factors for neural tube defects. Q. J. Med. 86:1993;703-708.
15. Wright M.E. A case-control study of maternal nutrition and neural tube defects in Northern Ireland. Midwifery. 11:1995;146-152.
16. 12 concentrations in pregnancies affected by neural tube defects. Z. Geburtshilfe Neonatol. 200:1996;176-180.
17. 12) in amniotic fluid. Prenat. Diagn. 18:1998;545-555.
18. Christensen B., Arbour L., Tran P., Leclerc D., Sabbaghian N., Platt R., Gilfix B.M., Rosenblatt D.S., Gravel R.A., Forbes P., Rozen R. Genetic polymorphisms in methylenetetrahydrofolate reductase and methionine synthase, folate levels in red blood cells, and risk of neural tube defects. Am. J. Med. Genet. 84:1999;151-157.
19. 12, calcium, and lead levels associated with neural tube defects. Am. J. Perinatol. 16:1999;373-378.
20. Suarez L., Hendricks K., Felkner M., Gunter E. Maternal serum b(12) levels and risk of neural tube defects in a Texas-Mexico border population. Ann. Epidemiol. 13:2003;81-88.
21. Brody L.C., Baker P.J., Chines P.S., Musick A., Molloy A.M., Kirke P.N., Ghosh S., Scott J.M., Mills J.L. Methionine synthase: high-resolution mapping of the human gene and evaluation as a candidate locus for neural tube defects. Mol. Genet. Metab. 67:1999;324-333. doi: 10.1006/mgme.1999.2881.
22. Morrison K., Edwards Y.H., Lynch S.A., Burn J., Hol F., Mariman E. Methionine synthase and neural tube defects. J. Med. Genet. 34:1997;958.
23. Van der Put N.M.J., van der Molen E.F., Kluijtmans L.A.J., Heil S.G., Trijbels J.M.F., Eskes T.K.A.B., van Oppenraaij-Emmerzaal D., Banjeree R., Blom H.J. Sequence analysis of the coding region of human methionine synthase: relevance to hyperhomocysteinaemia in neural-tube defects and vascular disease. Q. J. Med. 90:1997;511-517.
24. Shaw G.M., Todoroff K., Finnell R.H., Lammer E.J., Leclerc D., Gravel R.A., Rozen R. Infant methionine synthase variants and risk of spina bifida. J. Med. Genet. 36:1999;86-87.
25. Trembath D., Sherbondy A.L., Van Dyke D.C., Shaw G.M., Todoroff K., Lammer E.J., Finnell R.H., Marker S., Lerner G., Murray J.C. Teratology. 59:1999;331-341.
26. Johanning G.L., Tamura T., Johnston K.E., Wenstrom K.D. Cormorbidity of 5,10-mehtylenetetrahydrofolate reductase and methionine synthase gene polymorphisms and risk of neural tube defects. J. Med. Genet. 37:2000;949-951.
27. De Marco P., Calevo M.G., Moroni A., Arata L., Merello E., Finnell R.H., Zhu H., Andreussi L., Cama A., Capra V. Study of MTHFR and MS polymorphisms as risk factors for NTD in the Italian population. J. Hum. Genet. 47:2002;319-324.
28. Ledley F.D., Lumetta M.R., Zoghbi H.Y., VanTuinen P., Ledbetter S.A., Ledbetter D.H. Mapping of human methylmalonyl CoA mutase (MUT) locus on chromosome 6. Am. J. Hum. Genet. 42:1988;839-846.
29. Zoghbi H.Y., O'Brien W.E., Ledley F.D. Linkage relationships of the human methylmalonyl CoA mutase to the HLA and D6S4 loci on chromosome 6. Genomics. 3:1998;396-398.
30. Ledley F.D., Rosenblatt D.S. Mutations in mut methylmalonic acidemia: clinical and enzymatic correlations. Hum. Mutat. 9:1997;1-6.
31. 12. 1999;367-384 Wiley/Interscience, New York.
32. - methylmalonic aciduria. Hum. Mutat. S1:1998;S248-S250.
33. Ogasawara M., Matsubara Y., Mikami H., Narisawa K. Identification of two novel mutations in the methylmalonyl-CoA mutase gene with decreased levels of mutant mRNA in methylmalonic acidemia. Hum. Mol. Genet. 3:1994;867-872.
34. Acquaviva C., Benoist J.F., Callebaut I., Guffon N., Ogier de Baulny H., Touati G., Aydin A., Porquet D., Elion J. N219Y, a new frequent mutation among mut° forms of methylmalonic acidemia in caucasian patients. Eur. J. Hum. Genet. 9:2001;577-582.
35. Adams M.J. Jr., Khoury M.J., Scanlon K.S., Stevenson R.E., Knight G.J., Haddow J.E., Sylvester G.C., Cheek J.E., Henry J.P., Stabler S.P., Allen R.H. Elevated midtrimester serum methylmalonic acid levels as a risk factor for neural tube defects. Teratology. 51:1995;311-317.
36. Nham S.-U., Wilkemeyer M.F., Ledley F.D. Structure of the human methylmalonyl-CoA mutase (MUT) locus. Genomics. 8:1990;710-716.
37. - methylmalonic acidemia Am. J. Hum. Genet. 55:1994;42-50.
38. - methylmalonic aciduria. J. Clin. Invest. 89:1992;385-391.
39. Weinberg C.R., Wilcox A.J., Lie R.T. A log-linear approach to case-parent-triad data: assessing effects of disease genes that act either directly or through maternal effects and that may be subject to parent imprinting. Am. J. Hum. Genet. 62:1998;969-978.
40. Spielman R.S., McGinnis R.E., Ewens W.J. Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am. J. Hum. Genet. 52:1993;506-511.
41. 12) increases risk of spina bifida. Mol. Genet. Metab. 67:1999;317-323. doi: 10.1006/mgme.1999.2879.
42. Doolin M.T., Barbaux S., McDonnell M., Hoess K., Whitehead A.S., Mitchell L.E. Maternal genetic effects, exerted by genes involved in homocysteine remethylation, influence the risk of spina bifida. Am. J. Hum. Genet. 71:2002;1222-1226.
43. Zhu H., Wicker N.J., Shaw G.M., Lammer E.J., Hendricks S., Suarez L., Canfield M., Finnell R.H. Homocysteine remethylation enzyme polymorphisms and increased risks for neural tube defects. Mol. Genet. Metab. 78:2003;216-221. doi: 10.1016/S1096-7192(03)00008-8.
44. Magnus P., Magnus E.M., Berg K. Transcobalamins in the etiology of neural tube defects. Clin. Genet. 39:1991;309-310.
45. Afman L.A., Lievers K.J., van der Put N.M., Trijbels F.J., Blom H.J. Single nucleotide polymorphisms in the transcobalamin gene: relationship with transcobalamin concentrations and risk for neural tube defects. Eur. J. Hum. Genet. 10:2002;433-438.
46. Ledley F.D., Crane A.M., Lumetta M. Heterogeneous alleles and expression of methylmalonyl CoA mutase in mut methylmalonic acidemia. Am. J. Hum. Genet. 46:1990;539-547.
47. Wissell T.E., Tuttle D.J., Northam R.S., Simonds G.R. Major congenital neurologic malformations. Am. J. Dis. Child. 144:1990;61-67.
48. Elwood J.M., Little J., Elwood J.H. Epidemiology and Control of Neural Tube Defects. 1992;Oxford University Press, Oxford.
49. Feuchtbaum L.B., Currier R.J., Riggle S., Roberson M., Lorey F.W., Cunningham G.C. Neural tube defect prevalence in California (1990-1994): eliciting patterns by type of defect and maternal race/ethnicity. Genet. Test. 3:1999;265-272.
50. Rady P.L., Szucs S., Grady J., Hudnall D.S., Kellner L.H., Nitowsky H., Tyring S.K., Matalon R.K. Genetic polymorphisms of methylenetetrahydrofolate reductase (MTHFR) and methionine synthase reductase (MTRR) in ethnic populations in texas; a report of a novel MTHFR polymorphic site, G1793A. Am. J. Med. Genet. 107:2002;162-168.
51. Esfahani S.T., Cogger E.A., Caudill M.A. Heterogeneity in the prevalence of methylenetetrahydrofolate reductase gene polymorphisms in women of different ethnic groups. J. Am. Diet. Assoc. 103:2003;200-207.
52. Carlson C.S., Eberle M.A., Rieder M.J., Smith J.D., Kruglyak L., Nickerson D.A. Additional SNPs and linkage-disequilibrium analyses are necessary for whole-genome association studies in humans. Nat. Genet. 33:2003;518-521.